Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

NCT00459901 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Study halted by drug manufacturer

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Erlotinib and capecitabine

Sponsor

Peter Kozuch

Collaborators

[object Object]
[object Object]